Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FemSeven
- Development stage
- Unknown
- Lead developer
- Theramex
- Modality
- Small Molecules
- Administration
- Transdermal
01
Overview
FemSeven is a range of transdermal hormone replacement therapy (HRT) patches marketed by Theramex. The product line includes FemSeven (estradiol only), FemSeven Conti (estradiol and levonorgestrel), and FemSeven Sequi (estradiol and levonorgestrel in a sequential phase). Estradiol, a small molecule estrogen, works by supplementing declining hormone levels in menopausal women to alleviate symptoms such as hot flashes and night sweats. In the combination versions (Conti and Sequi), levonorgestrel is included as a progestogen to protect the lining of the womb (endometrium) from hyperplasia, which can be caused by unopposed estrogen. The patches are designed for once-weekly application, providing sustained release of the active ingredients through the skin.
- Brand names
- FemSevenFemSeven ContiFemSeven Sequi
- Other names
- estradiol transdermal patchestradiol + levonorgestrel transdermal patch
02
Targets
GPER1 (G protein-coupled estrogen receptor 1)ESR2 (ERβ)PR (Progesterone receptor)ESR1 (ERα)
Beyond the preview
Go deeper on FemSeven.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FemSeven.